Information
-
Trademark
-
76122110
-
International Classifications
-
Filing Date
August 23, 2000
24 years ago
-
Transaction Date
February 06, 2006
19 years ago
-
Status Date
September 18, 2002
22 years ago
-
Location Date
September 18, 2002
22 years ago
-
First Use Anywhere Date
June 01, 1996
28 years ago
-
First Use In Commerce Date
June 01, 1996
28 years ago
-
Status Code
602
-
Current Location
FILE REPOSITORY (FRANCONIA)
Employee Name
MICHOS, JOHN E
-
Attorney Docket Number
EPI-804T
Attorney Name
Viviana Amzel
Law Office Assigned Location Code
L50
-
Owners
Mark Drawing Code
5000
Mark Identification
GENE SILENCER
Case File Statements
- GS0421: Describing and providing medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vascoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Disease Syndrom (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating Supra Ventricular Tachycardia (SVT), adenosine stress test, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vascoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc., as well as metastatic cancers, e.g., cancers which metastasized to the lung(s), breast, liver and prostate
- PM0000: GENE SILENCER
Case File Event Statements
-
9/18/2002 - 22 years ago
6 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type: ABN2
-
2/6/2002 - 23 years ago
5 - NON-FINAL ACTION MAILED
Type: CNRT
-
9/27/2001 - 23 years ago
4 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
3/22/2001 - 23 years ago
3 - NON-FINAL ACTION MAILED
Type: CNRT
-
3/8/2001 - 23 years ago
2 - ASSIGNED TO EXAMINER
Type: DOCK
-
2/13/2001 - 24 years ago
1 - ASSIGNED TO EXAMINER
Type: DOCK